Bertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services - overview

Established

1991

Location

Paris, -, France

Primary Industry

Biotechnology

About

Founded in 1991 and based in Paris, France, Bertin Pharma operates as a pharmaceutical research company that offers research solutions and services on drug discovery and translational medicine industry.


Current Investors

Oncodesign SA

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals

Website

www.bertinpharma.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Bertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services - financials

Fiscal Year EndedDec 31, 2016
Revenue (USD)-
% Revenue Growth (YoY)-
EBITDA (USD)-
Operating Income (USD)-
Operating Margin-
% EBITDA Margin-
NET Income (USD)-
% Net Margin-

Bertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedBertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services-

Displaying 1 - 1 of 1

Bertin Pharma's metabolism, pharmacokinetics, bioanalysis and translational medicine services - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.